Allez à nos transactions
Placements Privés | Soins de la Santé

Eterus Capital has partnered with Dr. Martin to expand its dental clinic network

Dr. Martin Dental Clinic, a leading network of dental clinics in Slovakia, has received a significant investment from Eterus Capital and Ethernum Capital to support its expansion across the country. The group aims to become Slovakia’s largest dental care provider through a "buy-and-build" strategy, combining new clinic openings with acquisitions.

Eterus Capital is a private equity fund founded in 2008, specializing in supporting small and medium-sized enterprises with proven business models and growth potential. The fund focuses on minority investments, ensuring management control remains with the original shareholders. Over the years, Eterus Capital has provided more than US$41 million (€40 million) in funding to over 20 companies. Its portfolio includes prominent brands such as Sygic, HOPIN, eyerim, Saneca Pharmaceuticals, Groupsolver and MTBIKER.

Dr. Martin is a leading private dental care group in Slovakia, with over a decade of experience offering comprehensive services such as implantology, prosthetics and other restorative and aesthetic dental treatments. The group currently operates four modern dental clinics and a pediatric clinic under the Dr. Martinko brand, employing approximately 130 professionals.

Oaklins’ team in Slovakia advised Eterus Capital on this transaction.

Parties prenantes

Contacter l'équipe de la transaction

Boris Kostik

Associé
Bratislava, Slovaquie
Oaklins WOOD & Co.

Emma Jávorka

Analyste senior
Bratislava, Slovaquie
Oaklins WOOD & Co.

Transactions connexes

Valmiermuižas Alus has been acquired by Cēsu Alus
Placements Privés | Alimentation et Breuvages

Valmiermuižas Alus has been acquired by Cēsu Alus

Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.

En apprendre plus
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Soins de la Santé

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

En apprendre plus
Armira has signed an agreement to acquire a majority stake in Viabus
Placements Privés | Consommation et Détail

Armira has signed an agreement to acquire a majority stake in Viabus

Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.

En apprendre plus